PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: PTC299
Sponsor: PTC Therapeutics
Collaborators: United States Department of Defense